کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8690612 | 1581277 | 2018 | 8 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
علم عصب شناسی
عصب شناسی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge Les troubles neurocognitifs post-AVC légers et majeurs : du diagnostic à la prise en charge](/preview/png/8690612.png)
چکیده انگلیسی
Post-stroke neurocognitive disorders are frequent and associated with poorer prognosis. As they are frequently underdiagnosed, systematic identification of these cognitive disorders is needed. At least half of stroke survivors will develop a cognitive disorder of some type, mild in two-thirds of patients and severe (to dementia in some cases) in one third. Risk factors for post-stroke cognitive impairment, still to be defined for mild disorders, increase its frequency. The underlying mechanisms are not limited to vascular lesions since other types of lesions, particularly related to Alzheimer's disease, can be associated. Their identification is classically based on the Mini Mental Status Examination (MMSE) or the Montreal Cognitive Assessment (MoCA). These two tests have similar though only moderate sensitivity. Neuropsychological assessment, with evaluation of depression, is thus necessary in all patients at risk of cognitive disorders, or not fully recovering pre-stroke activities without obvious explanation, or with a MMSE score â¥Â 18 ( â¥Â 14 for MOCA). The neuropsychological assessment is now standardized, as are the Vascog diagnostic criteria. The management of post-stroke cognitive impairment is based on optimization of stroke prevention and treatment, rehabilitation when indicated and, in the case of dementia, on the usual general measures with cholinergic or memantine treatment when indicated for associated Alzheimer's disease.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Pratique Neurologique - FMC - Volume 9, Issue 2, April 2018, Pages 132-139
Journal: Pratique Neurologique - FMC - Volume 9, Issue 2, April 2018, Pages 132-139
نویسندگان
O. Godefroy, M. Barbay, M. Roussel,